IL17A and psoriasis: Specifically, tissue alterations seen in psoriasis are driven by the exaggerated production of pro-inflammatory cytokines and the lesion development is critically dependent on IL-23 and IL-17 (Lee et al., 2004; Piskin et al., 2006; van der Fits et al., 2009).